3,4-dihydroxyphenylacetic acid and 1-methyl-4-phenylpyridinium

3,4-dihydroxyphenylacetic acid has been researched along with 1-methyl-4-phenylpyridinium in 70 studies

Research

Studies (70)

TimeframeStudies, this research(%)All Research%
pre-199020 (28.57)18.7374
1990's34 (48.57)18.2507
2000's13 (18.57)29.6817
2010's3 (4.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cano, J; Machado, A; Santiago, M; Venero, JL1
Bagchi, SP1
de Vries, JB; Rollema, H; Santiago, M; Westerink, BH1
Caliguri, EJ; Johannessen, JN1
Bradbury, AJ; Costall, B; Jenner, PG; Kelly, ME; Marsden, CD; Naylor, RJ1
Bradbury, AJ; Costall, B; Domeney, AM; Jenner, PG; Marsden, CD; Naylor, RJ; Testa, B1
Bradbury, AJ; Costall, B; Domeney, AM; Jenner, PJ; Marsden, CD; Naylor, RJ1
Arai, Y; Kinemuchi, H; Kisara, K; Matsumura, T; Sakuma, I; Satoh, N; Tadano, T1
De Vries, J; Kranenborg, G; Kuhr, WG; Rollema, H; Van den Berg, C1
Chiueh, CC; Miyake, H1
de Vries, JB; Hofsteede, RM; Tuntler, J; Westerink, BH1
Alexander, GM; Castagnoli, N; Grothusen, JR; Matos, FF; Rollema, H1
Daigle, M; Di Paolo, T; Harnois, C; Marcotte, G1
Booth, RG; Castagnoli, N; Johnson, EA; Rollema, H; Trevor, AJ; Wu, EY1
Carlsson, A; Ekman, A; Engel, J; Magnusson, T; Pileblad, E; Snape, BM1
Duvoisin, RC; Heikkila, RE; Nicklas, WJ1
Heavens, RP; McBride, CS; Sirinathsinghji, DJ1
Booth, RG; Castagnoli, N; Rollema, H1
Chang, GD; Ramirez, VD2
Arora, PK; Harik, SI; Iacofano, LA; Sayre, LM1
Cohen, G; Mytilineou, C1
Damsma, G; de Vries, JB; Rollema, H; Tuntler, J; Westerink, BH1
Clavier, RM; Foulks, JG; Jones, K; Perry, TL; Wall, RA; Wright, JM; Yong, VW1
Cano, J; Machado, A; Santiago, M2
Corsini, GU; Fascetti, F; Fornai, F; Maggio, R; Vaglini, F1
Ambrosio, S; Bartrons, R; Calopa, M; Espino, A; Llorens, J; Rodriguez-Farré, E1
Albores, R; Collins, MA; Gearhart, D; Kindel, G; Neafsey, EJ; Raikoff, K; Tamayo, F1
Andersen, JK; Beal, MF; Breakefield, XO; Frim, DM; Isacson, O1
Ambrosio, S; Baron, S; Mahy, N; Perez, V; Unzeta, M1
Boireau, A; Doble, A; Dubédat, P; Meunier, M; Miquet, JM1
Giovanni, A; Heikkila, RE; Sieber, BA; Sonsalla, PK1
Giovanni, A; Heikkila, RE; Sonsalla, PK1
Dalia, A; Hadjiconstantinou, M; Neff, NH1
Castagnoli, N; D'Engelbronner, J; Igarashi, K; Rollema, H; Skolnik, M; Usuki, E1
Cano, J; Santiago, M; Westerink, BH1
Ambrosio, S; Bartrons, R; Cutillas, B; Espino, A; Ferrer, I; Tortosa, A1
Cano, J; Granero, L; Machado, A; Santiago, M1
McBean, GJ; O'Byrne, MB; Tipton, KF1
Ambrosio, S; Bartrons, R; Cutillas, B; Espino, A1
Ali, SF; Cadet, JL; Freyaldenhoven, TE1
Cano, J; Machado, A; Millan, F; Revuelta, M; Romero-Ramos, M; Venero, JL1
Hikosaka, O; Horikawa, HP; Nakazato, T1
Kitamura, Y; Kohno, Y; Nakazawa, M; Nomura, Y1
Ambrosio, S; Cutillas, B; Espejo, M1
Beal, MF; Hyman, BT; Klockgether, T; Liao, AW; Martinou, JC; Matthews, RT; Penney, JB; Schulz, JB; Yang, L1
Ambrosio, S; Cutillas, B; Espejo, M; Llorens, J1
Andreassen, OA; Beal, MF; Bonventre, JV; Chin, MR; Ferrante, RJ; Klivenyi, P; Wermer, M1
Flint Beal, M; Klivenyi, P; Oberley, T; St Clair, D; Wermer, M; Yang, L; Yen, HC1
Cano, J; Machado, A; Merino, M; Vizuete, ML1
Hindmarsh, JG; Jenner, P; Rose, S1
Castagnoli, K; Castagnoli, N; Palmer, S1
Barja, G; Fabre, E; Herrero, A; Leret, ML; Monserrat, J1
Almendral, JM; Del Río, J; Frechilla, D; García-Osta, A; Insausti, R; Rubio, MP; Ruiz-Golvano, P1
Andreassen, OA; Beal, MF; Ferrante, RJ; Klivenyi, P; Lancelot, E; Reif, D1
Disshon, KA; Dluzen, DE1
Eisenhofer, G; Harvey-White, J; Kirk, K; Kopin, IJ; Lamensdorf, I; Nechustan, A1
Arvin, M; Disshon, KA; Dluzen, DE; Fedorkova, L; Leipheimer, RE1
Kim, S; McCann, UD; Ricaurte, GA; Xie, T; Yuan, J1
Ferger, B; Teismann, P1
O'Byrne, MB; Tipton, KF1
Cory-Slechta, DA; Di Monte, DA; Langston, JW; Manning-Bog, AB; McCormack, AL; Thiffault, C; Thiruchelvam, M1
Cheng, XX; Han, JS; He, QH; Li, FQ; Liang, XB; Wang, XH; Wang, XM; Xue, B1
Battaglia, G; Biagioni, F; Bruno, V; Busceti, CL; Fornai, F; Molinaro, G; Nicoletti, F; Storto, M1
Gramsbergen, JB; Jakobsen, B; Møller Dall, A; Rosenblad, C; Zimmer, J1
Cui, Y; Jia, J; Luo, D; Sun, Z; Wang, H; Wang, X; Yang, J; Yu, F; Zhang, Q; Zheng, Y1
Nakayama, H; Sai, T; Uchida, K1
Chen, T; Hou, R; Li, C; Wu, C; Xu, S1
Chan, HM; Shao, Y1

Other Studies

70 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 1-methyl-4-phenylpyridinium

ArticleYear
In vivo protection of striatum from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists.
    Brain research, 1992, Jul-24, Volume: 586, Issue:2

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dizocilpine Maleate; Dopamine; Homovanillic Acid; Kinetics; Male; N-Methylaspartate; Neurotoxins; Rats; Rats, Inbred Strains; Time Factors

1992
Trace dosages of the neurotoxins MPTP and MPP+ may affect brain dopamine in vivo.
    Life sciences, 1992, Volume: 51, Issue:5

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; Male; Mice; Mice, Inbred C57BL; Reserpine

1992
Acute effects of intranigral application of MPP+ on nigral and bilateral striatal release of dopamine simultaneously recorded by microdialysis.
    Brain research, 1991, Jan-11, Volume: 538, Issue:2

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Corpus Striatum; Dialysis; Dopamine; Electrochemistry; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Neurons; Rats; Rats, Inbred Strains; Substantia Nigra

1991
Selective decrease in extracellular DOPAC concentrations in rat striatum following in vivo dialysis with low concentrations of MPP+.
    Brain research, 1991, May-10, Volume: 548, Issue:1-2

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dialysis; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Kinetics; Rats

1991
The neurotoxic actions of 1-methyl-4-phenylpyridine (MPP+) are not prevented by deprenyl treatment.
    Neuroscience letters, 1985, Jul-31, Volume: 58, Issue:2

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Limbic System; Mice; Motor Activity; Neurotransmitter Agents; Norepinephrine; Parkinson Disease, Secondary; Phenethylamines; Pyridinium Compounds; Selegiline; Serotonin

1985
The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
    Neuroscience letters, 1985, Oct-24, Volume: 61, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Diseases; Chemical Phenomena; Chemistry; Corpus Striatum; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Movement Disorders; Norepinephrine; Pyridines; Pyridinium Compounds; Rats; Serotonin; Substantia Nigra

1985
The neurotoxic actions of 6-hydroxydopamine infused into the rat substantia nigra.
    Neuroscience letters, 1986, Jun-18, Volume: 67, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Homovanillic Acid; Hydroxydopamines; Hydroxyindoleacetic Acid; Male; Movement Disorders; Neurotransmitter Agents; Oxidopamine; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Substantia Nigra

1986
Behavioral and biochemical changes following acute administration of MPTP and MPP+.
    Life sciences, 1987, Mar-30, Volume: 40, Issue:13

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Desipramine; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Motor Activity; Nomifensine; Pyridines; Pyridinium Compounds; Selegiline; Serotonin

1987
MPP+-induced efflux of dopamine and lactate from rat striatum have similar time courses as shown by in vivo brain dialysis.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 245, Issue:3

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dialysis; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Lactates; Lactic Acid; Male; Pyridinium Compounds; Rats; Rats, Inbred Strains; Time Factors

1988
Effects of MPP+ on the release of serotonin and 5-hydroxyindoleacetic acid from rat striatum in vivo.
    European journal of pharmacology, 1989, Jul-04, Volume: 166, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Anesthesia; Animals; Biogenic Monoamines; Corpus Striatum; Dose-Response Relationship, Drug; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Neurotoxins; Rats; Rats, Inbred Strains; Serotonin

1989
Use of calcium antagonism for the characterization of drug-evoked dopamine release from the brain of conscious rats determined by microdialysis.
    Journal of neurochemistry, 1989, Volume: 52, Issue:3

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Calcium; Corpus Striatum; Dialysis; Dopamine; Glutamates; Glutamic Acid; Haloperidol; Magnesium; Male; Nomifensine; Ouabain; Piperazines; Potassium; Pyridinium Compounds; Rats; Rats, Inbred Strains; Tetrodotoxin

1989
Comparison of the effects of intracerebrally administered MPP+ (1-methyl-4-phenylpyridinium) in three species: microdialysis of dopamine and metabolites in mouse, rat and monkey striatum.
    Neuroscience letters, 1989, Dec-04, Volume: 106, Issue:3

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Macaca fascicularis; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Inbred Strains; Species Specificity

1989
Retinal dopamine sensitivity to MPP+ toxicity: electrophysiological and biochemical evaluation.
    Neuroscience letters, 1989, Dec-15, Volume: 107, Issue:1-3

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Blood Vessels; Dopamine; Dose-Response Relationship, Drug; Electroretinography; Eye; Injections; Rabbits; Retina

1989
1-methyl-4-phenylpyridinium (MPP+) analogs: in vivo neurotoxicity and inhibition of striatal synaptosomal dopamine uptake.
    European journal of pharmacology, 1989, Jul-04, Volume: 166, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dialysis; Dopamine; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Nervous System Diseases; Neurons; Neurotoxins; Receptors, Dopamine; Synaptosomes

1989
The effects of 1-methyl-4-phenylpyridinium ion (MPP+) on the efflux and metabolism of endogenous dopamine in rat striatal slices.
    The Journal of pharmacy and pharmacology, 1988, Volume: 40, Issue:9

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Calcium; Corpus Striatum; Dopamine; In Vitro Techniques; Male; Neurotoxins; Neurotransmitter Uptake Inhibitors; Piperazines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Reserpine; Time Factors

1988
Studies on the mechanism of the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Advances in neurology, 1987, Volume: 45

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Mice; Mice, Inbred Strains; Pyridines; Pyridinium Compounds; Receptors, Dopamine; Selegiline

1987
Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Brain research, 1988, Mar-08, Volume: 443, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Benztropine; Calcium; Corpus Striatum; Dopamine; Kinetics; Male; Neurotoxins; Ouabain; Perfusion; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Reference Values; Sodium

1988
In vivo dopaminergic neurotoxicity of the 2-beta-methylcarbolinium ion, a potential endogenous MPP+ analog.
    European journal of pharmacology, 1988, Aug-09, Volume: 153, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Carbolines; Corpus Striatum; Dialysis; Dopamine; Male; Nervous System Diseases; Pyridinium Compounds; Rats; Rats, Inbred Strains; Receptors, Dopamine

1988
Effects on dopamine metabolism of MPTP and MPP+ infused through a push-pull cannula into the caudate nucleus of awake adult male rats.
    Brain research, 1987, Oct-20, Volume: 424, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Dopamine; Infusions, Parenteral; Kinetics; Male; Neurotoxins; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Stereotaxic Techniques

1987
The mechanism of action of MPTP and MPP+ on endogenous dopamine release from the rat corpus striatum superfused in vitro.
    Brain research, 1986, Mar-12, Volume: 368, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Drug Interactions; Male; Perfusion; Potassium; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains

1986
Comparative toxicity of MPTP, MPP+ and 3,3-dimethyl-MPDP+ to dopaminergic neurons of the rat substantia nigra.
    European journal of pharmacology, 1986, May-13, Volume: 124, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Herbicides; Homovanillic Acid; Male; Neurons; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Receptors, Dopamine; Substantia Nigra

1986
Tissue culture model for studying MPTP toxicity to dopamine neurons.
    Advances in neurology, 1987, Volume: 45

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Culture Techniques; Dopamine; Homovanillic Acid; Mesencephalon; Neurons; Pyridines; Pyridinium Compounds; Rats; Receptors, Dopamine

1987
The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis.
    Naunyn-Schmiedeberg's archives of pharmacology, 1987, Volume: 336, Issue:5

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Corpus Striatum; Dialysis; Dopamine; Haloperidol; Homovanillic Acid; Male; Morphine; Neurotoxins; Nucleus Accumbens; Piperazines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Septal Nuclei; Tetrodotoxin

1987
Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse.
    Neuroscience letters, 1985, Aug-05, Volume: 58, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; Pyridines; Pyridinium Compounds; Substantia Nigra

1985
Effects of age and dopamine agonists and antagonists on striatal dopamine release in the rat: an in vivo microdialysis study.
    Mechanisms of ageing and development, 1993, Volume: 67, Issue:3

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dialysis; Dopamine; Dopamine Agents; Dopamine Antagonists; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Rats; Rats, Wistar

1993
(+)MK-801 prevents the DDC-induced enhancement of MPTP toxicity in mice.
    Brain research, 1994, Dec-30, Volume: 668, Issue:1-2

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Ditiocarb; Dizocilpine Maleate; Dopamine; Drug Synergism; Haplorhini; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Piperazines; Selegiline; Substantia Nigra; Tyrosine 3-Monooxygenase

1994
Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion.
    Brain research, 1995, Jan-09, Volume: 669, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; gamma-Aminobutyric Acid; Homovanillic Acid; Male; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley

1995
Methyl-beta-carbolinium analogs of MPP+ cause nigrostriatal toxicity after substantia nigra injections in rats.
    Brain research, 1995, Mar-27, Volume: 675, Issue:1-2

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, High Pressure Liquid; Dopamine; Image Processing, Computer-Assisted; Injections; Male; Neostriatum; Rats; Rats, Sprague-Dawley; Substantia Nigra

1995
Elevation of neuronal MAO-B activity in a transgenic mouse model does not increase sensitivity to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Brain research, 1994, Sep-05, Volume: 656, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Monoamine Oxidase; Neostriatum; Neurons; Substantia Nigra; Tyrosine 3-Monooxygenase

1994
Sex-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine treatment may be related to differences in monoamine oxidase B.
    Neuroscience letters, 1994, Aug-01, Volume: 176, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Estrus; Female; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Neostriatum; Sex Characteristics

1994
Riluzole and experimental parkinsonism: partial antagonism of MPP(+)-induced increase in striatal extracellular dopamine in rats in vivo.
    Neuroreport, 1994, Oct-27, Volume: 5, Issue:16

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Excitatory Amino Acid Antagonists; Extracellular Space; Homovanillic Acid; Male; Parkinson Disease, Secondary; Rats; Riluzole; Thiazoles

1994
Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 270, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Cocaine; Dopamine; Guanethidine; Male; Mice; Microdialysis; Monoamine Oxidase; MPTP Poisoning; Neostriatum; Neurons; Premedication; Rats; Rats, Sprague-Dawley; Species Specificity; Synaptosomes

1994
Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 2: Central administration of 1-methyl-4-phenylpyridinium.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 270, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Cocaine; Dopamine; Dose-Response Relationship, Drug; Guanethidine; Male; Mice; Monoamine Oxidase; MPTP Poisoning; Neostriatum; Premedication; Rats; Rats, Sprague-Dawley; Species Specificity

1994
GM1 ganglioside improves dopaminergic markers of rat mesencephalic cultures treated with MPP+.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1993, Volume: 13, Issue:7

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic-L-Amino-Acid Decarboxylases; Cells, Cultured; Cytarabine; Dopamine; G(M1) Ganglioside; Gestational Age; Immunohistochemistry; Kinetics; Mesencephalon; Neuroglia; Neurons; Neurotoxins; Rats; Rats, Sprague-Dawley; Time Factors; Tyrosine 3-Monooxygenase

1993
MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 268, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; Haloperidol; Lactates; Lactic Acid; Male; Mice; Microdialysis; Mitochondria, Liver; Nervous System; Pyridinium Compounds; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Serotonin; Serotonin

1994
Are bilateral nigrostriatal dopaminergic pathways functionally linked in the rat brain? A microdialysis study in conscious rats.
    Brain research, 1993, Nov-19, Volume: 628, Issue:1-2

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Baclofen; Corpus Striatum; Dopamine; Kainic Acid; Male; Microdialysis; Muscimol; Neural Pathways; Picrotoxin; Rats; Rats, Wistar; Substantia Nigra; Synaptic Transmission; Tetrodotoxin

1993
Chronic effects of single intrastriatal injections of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium studied by microdialysis in freely moving rats.
    Brain research, 1995, Oct-16, Volume: 695, Issue:2

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Dopamine Agents; Extracellular Space; Homovanillic Acid; Immunohistochemistry; Injections; Male; Microdialysis; Neostriatum; Oxidopamine; Rats; Rats, Sprague-Dawley; Substantia Nigra; Sympatholytics

1995
Complex I inhibitor effect on the nigral and striatal release of dopamine in the presence and absence of nomifensine.
    European journal of pharmacology, 1995, Jul-14, Volume: 280, Issue:3

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Microdialysis; Nomifensine; Rats; Rats, Wistar; Rotenone; Substantia Nigra; Uncoupling Agents

1995
The effects of 1-methyl-4-phenylpyridinium ion on biogenic amine levels in rat substantia nigra.
    Biochemical Society transactions, 1996, Volume: 24, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Catecholamines; Chromatography, High Pressure Liquid; Dopamine; Female; Homovanillic Acid; In Vitro Techniques; Neurotoxins; Norepinephrine; Rats; Rats, Wistar; Serotonin; Substantia Nigra

1996
Nigral and striatal comparative study of the neurotoxic action of 1-methyl-4-phenylpyridinium ion: involvement of dopamine uptake system.
    Journal of neurochemistry, 1996, Volume: 66, Issue:3

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Extracellular Space; Male; Neurotoxins; Nomifensine; Perfusion; Rats; Rats, Wistar; Substantia Nigra

1996
MPP+ toxicity in rat striatal slices: relationship between non-selective effects and free radical production.
    Neurochemical research, 1996, Volume: 21, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Free Radicals; In Vitro Techniques; Malondialdehyde; Rats; Rats, Sprague-Dawley

1996
The dopamine-depleting effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in CD-1 mice are gender-dependent.
    Brain research, 1996, Oct-07, Volume: 735, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Female; Homovanillic Acid; Male; Mice; Mice, Inbred Strains; Sex Characteristics; Time Factors

1996
Less induced 1-methyl-4-phenylpyridinium ion neurotoxicity on striatal slices from guinea-pigs fed with a vitamin C-deficient diet.
    Neuroscience, 1997, Volume: 77, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Amino Acids; Animals; Ascorbic Acid Deficiency; Body Weight; Central Nervous System Diseases; Dehydroascorbic Acid; Dopamine; Dopamine Agents; Female; Guinea Pigs; Homovanillic Acid; Neostriatum; Organ Culture Techniques; Tyrosine 3-Monooxygenase; Uric Acid

1997
Duration of catalepsy correlates with increased intrastriatal sulpiride.
    European journal of pharmacology, 1997, May-12, Volume: 326, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Catalepsy; Dopamine; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Electrochemistry; Homovanillic Acid; Male; Microinjections; Neostriatum; Rats; Rats, Sprague-Dawley; Sulpiride; Time Factors

1997
Inhibitory effects of talipexole and pramipexole on MPTP-induced dopamine reduction in the striatum of C57BL/6N mice.
    Japanese journal of pharmacology, 1997, Volume: 74, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Azepines; Benzothiazoles; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Homovanillic Acid; In Vitro Techniques; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Neostriatum; Pramipexole; Synaptosomes; Thiazoles

1997
7-Nitroindazole prevents dopamine depletion caused by low concentrations of MPP+ in rat striatal slices.
    Neurochemistry international, 1998, Volume: 33, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Agents; In Vitro Techniques; Indazoles; Male; Rats; Rats, Sprague-Dawley

1998
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1998, Oct-15, Volume: 18, Issue:20

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Apoptosis; Brain Chemistry; Caspase 2; Caspase Inhibitors; Caspases; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Female; Free Radicals; Gene Expression; Homovanillic Acid; Injections, Intraperitoneal; Male; Mazindol; Mice; Mice, Transgenic; MPTP Poisoning; Neurons; Neurotoxins; Oxidative Stress; Pregnancy; Proto-Oncogene Proteins c-bcl-2; Radioligand Assay; Tritium; Tyrosine

1998
Intrastriatal grafts of fetal mesencephalic cell suspensions in MPP+-lesioned rats: a microdialysis study in vivo.
    Neurochemical research, 1998, Volume: 23, Issue:10

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Fetal Tissue Transplantation; Homovanillic Acid; Immunohistochemistry; Male; Mesencephalon; Microdialysis; Rats; Rats, Sprague-Dawley

1998
Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity.
    Journal of neurochemistry, 1998, Volume: 71, Issue:6

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Cell Count; Corpus Striatum; Cytosol; Dopamine Agents; Drug Resistance; Homovanillic Acid; Mice; Mice, Knockout; Neurotoxins; Phospholipases A; Phospholipases A2; Substantia Nigra; Tyrosine 3-Monooxygenase

1998
Manganese superoxide dismutase overexpression attenuates MPTP toxicity.
    Neurobiology of disease, 1998, Volume: 5, Issue:4

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain Diseases; Cerebral Cortex; Dopamine; Dopamine Agents; Gene Expression; Humans; Mice; Mice, Transgenic; Microscopy, Immunoelectron; Mitochondria; Neurons; Superoxide Dismutase; Transgenes

1998
The non-NMDA glutamate receptor antagonists 6-cyano-7-nitroquinoxaline-2,3-dione and 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline, but not NMDA antagonists, block the intrastriatal neurotoxic effect of MPP+.
    Journal of neurochemistry, 1999, Volume: 73, Issue:2

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine Agents; Excitatory Amino Acid Antagonists; Female; Homovanillic Acid; Kynurenic Acid; Microinjections; Neuroprotective Agents; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Tyrosine 3-Monooxygenase

1999
Neuronal nitric oxide synthase inhibition reduces MPP+-evoked hydroxyl radical formation but not dopamine efflux in rat striatum.
    Journal of neural transmission (Vienna, Austria : 1996), 1999, Volume: 106, Issue:5-6

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydroxybenzoates; Hydroxyl Radical; In Vitro Techniques; Indazoles; Male; Microdialysis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats; Rats, Wistar

1999
Neuroprotection by (R)-deprenyl and 7-nitroindazole in the MPTP C57BL/6 mouse model of neurotoxicity.
    Neurobiology (Budapest, Hungary), 1999, Volume: 7, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Cattle; Corpus Striatum; Dopamine; Indazoles; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Neuroprotective Agents; Neurotoxins; Selegiline

1999
Effect of MPTP on brain mitochondrial H2O2 and ATP production and on dopamine and DOPAC in the striatum.
    Journal of physiology and biochemistry, 1999, Volume: 55, Issue:4

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Adenosine Triphosphate; Animals; Brain; Corpus Striatum; Dopamine; Hydrogen Peroxide; Male; MPTP Poisoning; Oxidative Stress; Rats; Rats, Wistar

1999
Implanted BDNF-producing fibroblasts prevent neurotoxin-induced serotonergic denervation in the rat striatum.
    Brain research. Molecular brain research, 2000, Mar-29, Volume: 76, Issue:2

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; beta-Galactosidase; Brain-Derived Neurotrophic Factor; Cell Line; Cell Transplantation; Cerebral Cortex; Corpus Striatum; Denervation; Dopamine; Fibroblasts; Gene Library; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Neurotoxins; Protein Precursors; Rats; Recombinant Proteins; Serotonin; Transfection

2000
Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity.
    Neuroreport, 2000, Apr-27, Volume: 11, Issue:6

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Isoquinolines; Male; Mice; MPTP Poisoning; Neurons; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Substantia Nigra; Tetrahydroisoquinolines; Thiophenes; Tyrosine 3-Monooxygenase

2000
Estrogen reduces acute striatal dopamine responses in vivo to the neurotoxin MPP+ in female, but not male rats.
    Brain research, 2000, Jun-16, Volume: 868, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Estrogens; Extracellular Space; Female; Herbicides; Male; Microdialysis; Nerve Degeneration; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Sex Characteristics

2000
3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells.
    Brain research, 2000, Jun-23, Volume: 868, Issue:2

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Dopamine; Energy Metabolism; Enzyme Inhibitors; Estrogens, Non-Steroidal; Fluorenes; Hydantoins; Isoflavones; Mitochondria; Neurons; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; PC12 Cells; Phenylethyl Alcohol; Rats; Rotenone

2000
Estrogen modulates responses of striatal dopamine neurons to MPP(+): evaluations using in vitro and in vivo techniques.
    Brain research, 2000, Jul-28, Volume: 872, Issue:1-2

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Estrogens; Female; In Vitro Techniques; Microelectrodes; Microinjections; Neurons; Neuroprotective Agents; Nucleus Accumbens; Ovariectomy; Oxidation-Reduction; Perfusion; Rats

2000
Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2000, Oct-15, Volume: 20, Issue:20

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature; Brain; Carrier Proteins; Cells, Cultured; Dopamine; Dopamine Plasma Membrane Transport Proteins; Intracellular Fluid; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Methamphetamine; Mice; Nerve Tissue Proteins; Neuroblastoma; Neurons; Rats; Rats, Sprague-Dawley; Temperature

2000
Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease.
    Synapse (New York, N.Y.), 2001, Volume: 39, Issue:2

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Count; Cyclooxygenase 1; Cyclooxygenase 2; Disease Models, Animal; Dopamine; Homovanillic Acid; Isoenzymes; Male; Meloxicam; Membrane Proteins; Mice; Mice, Inbred C57BL; Motor Activity; Neostriatum; Neuroprotective Agents; Parkinsonian Disorders; Prostaglandin-Endoperoxide Synthases; Substantia Nigra; Thiazines; Thiazoles; Tyrosine 3-Monooxygenase

2001
Inhibition of the neuronal isoform of nitric oxide synthase significantly attenuates 1-methyl-4-phenylpyridinium (MPP(+)) toxicity in vitro.
    Journal of neural transmission (Vienna, Austria : 1996), 2002, Volume: 109, Issue:5-6

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dizocilpine Maleate; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Female; Homovanillic Acid; In Vitro Techniques; Indazoles; L-Lactate Dehydrogenase; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitroarginine; Rats; Rats, Wistar

2002
Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat.
    Neurobiology of disease, 2002, Volume: 10, Issue:2

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Biomarkers; Dopamine; Environmental Exposure; gamma-Aminobutyric Acid; Gliosis; Herbicides; Homovanillic Acid; Humans; Injections, Intraperitoneal; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Paraquat; Parkinson Disease; Parkinson Disease, Secondary; Parkinsonian Disorders; Risk Factors; Substantia Nigra; Tyrosine 3-Monooxygenase

2002
Neurotrophic and neuroprotective effects of tripchlorolide, an extract of Chinese herb Tripterygium wilfordii Hook F, on dopaminergic neurons.
    Experimental neurology, 2003, Volume: 179, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Axotomy; Brain-Derived Neurotrophic Factor; Cell Division; Cells, Cultured; Corpus Striatum; Diterpenes; Dopamine; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Homovanillic Acid; Immunohistochemistry; Immunosuppressive Agents; Medial Forebrain Bundle; Neurites; Neurons; Neuroprotective Agents; Phenanthrenes; Rats; Rats, Sprague-Dawley; Recovery of Function; RNA, Messenger; Tripterygium

2003
Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004, Jan-28, Volume: 24, Issue:4

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Homovanillic Acid; Mice; Mice, Knockout; MPTP Poisoning; Neuroprotective Agents; Pyridines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Substantia Nigra; Survival Rate; Synaptosomes

2004
Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF.
    The European journal of neuroscience, 2005, Volume: 21, Issue:11

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Cell Differentiation; Cell Proliferation; Cell Size; Cells, Cultured; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Glial Cell Line-Derived Neurotrophic Factor; Mice; Mice, Inbred C57BL; Nerve Degeneration; Nerve Growth Factors; Neurons; Neuroprotective Agents; Neurotoxins; Organ Culture Techniques; Parkinsonian Disorders; Recovery of Function; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase

2005
Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
    European journal of pharmacology, 2009, Sep-01, Volume: 617, Issue:1-3

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Cell Death; Cell Line; Dopamine; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Neostriatum; Neurons; Neuroprotective Agents; Polysaccharides; Tyrosine 3-Monooxygenase

2009
Biochemical evaluation of the neurotoxicity of MPTP and MPP⁺ in embryonic and newborn mice.
    The Journal of toxicological sciences, 2013, Volume: 38, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Newborn; Brain; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Female; Homovanillic Acid; Injections, Intraperitoneal; Male; Maternal-Fetal Exchange; Mice; Mice, Inbred C57BL; Monoamine Oxidase; MPTP Poisoning; Pregnancy; Tyrosine 3-Monooxygenase

2013
MPTP/MPP+ suppresses activation of protein C in Parkinson's disease.
    Journal of Alzheimer's disease : JAD, 2015, Volume: 43, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Antigens, CD; Brain; Cells, Cultured; Dopamine; Endothelial Cells; Endothelial Protein C Receptor; Glial Fibrillary Acidic Protein; HEK293 Cells; Humans; Male; Mice, Inbred C57BL; Microvessels; MPTP Poisoning; Nerve Tissue Proteins; Protein C; Receptors, Cell Surface; RNA, Small Interfering; Sp1 Transcription Factor; Thrombomodulin

2015
Effects of methylmercury on dopamine release in MN9D neuronal cells.
    Toxicology mechanisms and methods, 2015, Volume: 25, Issue:8

    Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; alpha-Synuclein; Animals; Cell Line; Cell Survival; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Dose-Response Relationship, Drug; Environmental Pollutants; Gene Expression Regulation; Homovanillic Acid; Kinetics; Methylmercury Compounds; Mice; Monoamine Oxidase; Nerve Tissue Proteins; RNA, Messenger; Tyrosine 3-Monooxygenase

2015